Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats

Journal of the American Society of Nephrology

Volumn 11, Issue 3, 2000, Pages 477-489

  Macconi, Daniela ^a   Ghilardi, Marina ^a   Bonassi, Maria Enrica ^a   Mohamed, Ehab I ^a   Abbate, Mauro ^a   Colombi, Francesca ^a   Remuzzi, Giuseppe ^a,b   Remuzzi, Andrea ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GLOMERULUS BASEMENT MEMBRANE; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PERMEABILITY; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 0034094361     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Galaske R, Baladamus CA, Stolte H: Plasma protein handling in the rat kidney: Micropuncture experiments in the acute heterologous phase of anti-GBM-nephritis. Pflügers Arch 375: 269-277, 1978
2. Tojo A, Hitoshi E: Intrarenal handling of proteins in rats using fractional micropuncture technique. Am J Physiol 263: F601-F606, 1992
3. Remuzzi G: Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury. Curr Opin Nephrol Hypertens 4: 339-342, 1995
4. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384-394, 1990
5. Hirschberg R: Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions. J Clin Invest 98: 116-124, 1996
6. Eddy AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 5: 1273-1278, 1994
7. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612-619, 1985
8. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930, 1986
9. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993-2000, 1986
10. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85: 541-549, 1990
11. Hommel E, Parving HH, Mathiesen E, Edsberg B, Damkjær M, Giese J: Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 293: 467-470, 1986
12. Parving HH, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. Br Med J 297: 1086-1091, 1988
13. Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293: 471-474, 1986
14. Marre M, Le Blanc H, Suarez L: Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 294: 1448-1452, 1987
15. The GISEN Group: Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349: 1857-1863, 1997
16. Yoshioka T, Rennke HG, Salant DJ, Deen WM, Ichikawa I: Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: A. study in early passive Heymann nephritis. Circ Res 61: 531-538, 1987
17. Halbach GR, Alt JM, Brunkhorst R, Frei U, Kuhn K, Stolte H: Single nephron hyperfiltration and proteinuria in a newly selected rat strain with superficial glomeruli. Ren Physiol 9: 317-325, 1986
18. Remuzzi A, Puntorieri S, Alfano M, Macconi D, Abbate M, Bertani T, Remuzzi G: Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury. Lab Invest 67: 572-579, 1992
19. Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G: Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats. Exp Nephrol 4: 19-25, 1996
20. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D: Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 32: 78-83, 1987
21. Morelli E, Loon N, Meyer TW, Peters W, Myers BD: Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 39: 76-82, 1990
22. Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G: Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 39: 1267-1273, 1991
23. Ene-Iordache B, Imberti O, Foglieni C, Remuzzi G, Bertani T, Remuzzi A: Effects of angiotensin-converting enzyme inhibition on glomerular capillary wall ultrastructure in MWF/Ztm rats. J Am Soc Nephrol 5: 1378-1384, 1994
24. Farquhar MG: The glomerular basement membrane: A selective macromolecular filter. In: Cell Biology of Extracellular Matrix, edited by Hay ED, New York, Plenum Press, 1981, pp 335-378
25. Fujigaki Y, Nagase M, Kobayasi S, Hidaka S, Shimomura M, Hishida A: Intra-GBM site of the functional filtration barrier for endogenous proteins in rats. Kidney Int 43: 567-574, 1993
26. Robinson GB, Walton HA: Glomerular basement membrane as a compressible ultrafilter. Microvasc Res 38: 36-48, 1989
27. Daniels BS, Hauser EB, Deen WM, Hostetter TH: Glomerular basement membrane: In vitro studies of water and protein permeability. Am J Physiol 262: F919-F926, 1992
28. Daniels BS: Increased albumin permeability in vitro following alterations of glomerular charge is mediated by the cells of the filtration barrier. J Lab Clin Med 124: 224-230, 1994
29. Daniels BS: The role of the glomerular epithelial cell in the maintenance of the glomerular filtration barrier. Am J Nephrol 13: 318-323, 1993
30. Rennke HG: How does glomerular epithelial cell injury contribute to progressive glomerular damage? Kidney Int 45: S58-S63, 1994
31. Laurens W, Battaglia C, Foglieni C, De Vos R, Malanchini B, Van Damme B, Vanrenterghem Y, Remuzzi G, Remuzzi A: Direct podocyte damage in the single nephron leads to albuminuria in vivo. Kidney Int 47: 1078-1086, 1995
32. Blantz RC, Gabbai FB, Peterson O, Wilson CB, Kihara I, Kawachi H, Shimizu F, Yamamoto T: Water and protein permeability is regulated by the glomerular epithelial slit diaphragm. J Am Soc Nephrol 4: 1957-1964, 1994
33. Kurihara H, Anderson JM, Kerjaschki D, Farquhar MG: The altered glomerular filtration slits seen in puromycin aminonucleoside nephrosis and protamine sulfate-treated rats contain the tight junction protein ZO-1. Am J Pathol 141: 805-816, 1992
34. Ligler FS, Robinson GB, Byrne J: A new method for the isolation of renal basement membranes. Biochim Biophys Acta 468: 327-340, 1977
35. Read SM, Northcote DH: Minimization of variations in the response to different proteins of the Coomassie blue G dye-binding assay for protein. Anal Biochem 116: 53-64, 1981
36. McLean IW, Nakane PF: Periodate-lysine paraformaldehyde fixative: A new fixative for immunoelectron microscopy. J Histochem Cytochem 22: 1077-1083, 1974
37. Tokuyasu K: Immunocytochemistry on ultrathin frozen sections. Histochem J 12: 381-403, 1980
38. Laemnli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 221: 680-685, 1970
39. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979
40. Pagtalunan ME, Rasch R, Rennke HG, Meyer TW: Morphometric analysis of effects of angiotensin II on glomerular structure in rats. Am J Physiol 268: F82-F88, 1995
41. Seefeldt T, Bohman S-O, Gundersen HJG, Maunsbach AB, Petersen VP, Olsen S: Quantitative relationship between glomerular foot process width and proteinuria in glomerulonephritis. Lab Invest 44: 541-546, 1981
42. Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 47: 1-9, 1980
43. Fitzgibbon WR, Webster SK, Imamura A, Ploth DW, Hutchison FN: Effect of dietary protein and enalapril on proximal tubular delivery and absorption of albumin in nephrotic rats. Am J Physiol 260: F986-F996, 1996
44. Remuzzi A, Remuzzi G: Glomerular perm-selective function. Kidney Int 45: 398-402, 1994
45. Remuzzi A, Imberti O, Puntorieri S, Malanchini B, Macconi D, Magrini L, Bertani T, Remuzzi G: Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in the rat. Am J Physiol 267: F1034-F1044, 1994
46. Robinson GB, Walton HA: Ultrafiltration through basement membrane. In: Renal Basement Membranes in Health and Diseases, edited by Price RG, Hudson BG, New York, London, Academic Press, 1987, pp 147-161
47. Bolton GR, Deen WM, Daniels BS: Assessment of the charge selectivity of glomerular basement membrane using Ficoll sulfate. Am J Physiol 274: F889-F896, 1998
48. Schnabel E, Anderson JM, Farquhar MG: The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium. J Cell Biol 111: 1255-1263, 1990
49. Kurihara H, Anderson JM, Farquhar MG: Diversity among tight junctions in rat kidney: Glomerular slit diaphragms and endothelial junctions express only one isoform of the tight junction protein ZO-1. Proc Natl Acad Sci USA 89: 7075-7079, 1992
50. Anderson JM, Van Itallie CM: Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 269: G467-G475, 1995
51. Kawachi H, Kurihara H, Topham PS, Brown D, Shia MA, Orikasa M, Shimizu F, Salant DJ: Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes. Am J Physiol 273: F984-F993, 1997
52. Fujiwara Y, Kitamura E, Ueda N, Fukunaga M, Orita Y, Kamada T: Mechanism of action of angiotensin II on isolated rat glomeruli. Kidney Int 36: 985-991, 1989
53. Yoshioka T, Ichikawa A, Fogo A: Reactive oxygen metabolites causes massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 2: 902-912, 1991
54. Coers W, Vos JTWM, Van Der Meide PH, Van Der Horst MLC, Huitema S, Weening JJ: Interferon-gamma (IFN-γ) and IL-4 expressed during mercury-induced membranous nephropathy are toxic for cultured podocytes. Clin Exp Immunol 102: 297-307, 1995
55. Staddon JM, Herrenknecht K, Smales C, Rubin LL: Evidence that tyrosine phosphorylation may increase tight junction permeability. J Cell Sci 108: 609-619, 1995
56. Collares-Buzato CB, Jepson MA, Simmons NL, Hirst BH: Increased tyrosine phosphorylation causes redistribution of adherens junction and tight junction proteins and perturbs paracellular barrier function in MDCK epithelia. Eur J Cell Biol 76: 85-92, 1998
57. Kurihara H, Anderson JM, Farquhar MG: Increased tyr phosphorylation of ZO-1 during modification of tight junctions between glomerular foot processes. Am J Physiol 268: F514-F524, 1995
58. Leduc I, Meloche S: Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells. J Biol Chem 270: 4401-4404, 1995
59. - channels in mesangial cells. Am J Physiol 270: C1834-C1842, 1996